Crescent Biopharma, Inc. (CBIO) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 123.51M |
| Enterprise Value | -88.04M |
| P/E Ratio | -1.61 |
| PEG Ratio | 0.01 |
| Price/Sales Ratio | 40.77 |
| Price/Book Ratio | 2.91 |
| Enterprise/Revenue | 24.98 |
| Enterprise/EBITDA | -1.87 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -13.64 |
| Operating Margin | -13.73 |
| Return On Assets | -0.81 |
| Return On Equity | -1.01 |
| Revenue | 10.84M |
| Revenue/Share | 0.39 |
| Gross Profit | 10.84M |
| EBITDA | -149.67M |
| Net Income | -153.94M |
| Diluted EPS | -14.78 |
| Total Cash | 189.16M |
| Total Cash/Share | 6.22 |
| Total Debt | 1.54M |
| Total Debt/Equity | 0.01 |
| Current Ratio | 13.78 |
| Book Value Per Share | 6.05 |
| 52-Week Change | 14.84 |
| 52-Week High | 27.41 |
| 52-Week Low | 8.72 |
| Moving Average 50 Days | 19.82 |
| Moving Average 200 Days | 14.29 |
| Average Volume | 277,890 |
| Shares Outstanding | 27.57M |
| % Held by Institutions | 24.12 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:100 |
| Last Split Date | June 16, 2025 |